Open Access

[Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1

  • Authors:
    • Yan Li
    • Lifen Zhao
    • Nana Li
    • Yuan Miao
    • Huimin Zhou
    • Li Jia
  • View Affiliations

  • Published online on: March 13, 2019     https://doi.org/10.3892/or.2019.7057
  • Pages: 3148-3148
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

May-2019
Volume 41 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Li Y, Zhao L, Li N, Miao Y, Zhou H and Jia L: [Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1. Oncol Rep 41: 3148-3148, 2019
APA
Li, Y., Zhao, L., Li, N., Miao, Y., Zhou, H., & Jia, L. (2019). [Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1. Oncology Reports, 41, 3148-3148. https://doi.org/10.3892/or.2019.7057
MLA
Li, Y., Zhao, L., Li, N., Miao, Y., Zhou, H., Jia, L."[Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1". Oncology Reports 41.5 (2019): 3148-3148.
Chicago
Li, Y., Zhao, L., Li, N., Miao, Y., Zhou, H., Jia, L."[Corrigendum] miR-9 regulates the multidrug resistance of chronic myelogenous leukemia by targeting ABCB1". Oncology Reports 41, no. 5 (2019): 3148-3148. https://doi.org/10.3892/or.2019.7057